The Billion Molecules against Covid19 Grand Challenge aims to screen billions of molecules with blocking interactions on SARS-CoV-2

BCC marks the second non-melanoma skin cancer for which Libtayo has demonstrated first-in-class data, the firms note

The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints

The move will establish Menarini’s presence in the US biopharma market

The Day of Hand Hygiene takes place annually on 5 May. Originally initiated by the World Health Organization […]

Korean researchers have screened 48 FDA-approved drugs against SARS-CoV-2, and found that two, that are already FDA-approved for […]

Updated Date: Mon, 27 Apr 2020 00:00:00 EDT

Updated Date: Mon, 27 Apr 2020 00:00:00 EDT

Updated Date: Mon, 27 Apr 2020 00:00:00 EDT

Updated Date: Mon, 27 Apr 2020 00:00:00 EDT